Compare Effects of Dressing With Honey and EUSOL
A Comparative Study Between the Use of Topical Honey and EUSOL Dressing in Necrotizing Fascitis Wounds
1 other identifier
interventional
326
1 country
1
Brief Summary
Honey is super saturated solution containing sugar derived from nectar gathered by honeybee. Honey is viscus supersaturated solution mainly composed of sugar and water along with minor constituents such as minerals, vitamins, amino acids, organic acids, flavonoids, and other phenolic compound and aromatic substances. Honey contents according to percentages are fructose 38.6%, glucose 31%, water 17%, lactose 7.2%, larger sugars 4.7% and rest of micronutrients and elemental compounds are 1.5%. Honey enhances wound healing by removing slough and necrotic tissue from wound. It promotes wound healing by increasing angiogenesis, granulation and epithelization. Honey possess antimicrobial activity against bacteria like methicillin resistant staphylococcus aureus, vancomycin resistant Escherichia Coli, pseudomonas aeruginosa, and many other species. It also has activity against some yeast species such as aspergillus and penicillium. Honey used for dressing will be 'Langnese Honey". Langnese honey is raw honey / unprocessed packed as collected, quality and quantity will be same for patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2020
CompletedFirst Submitted
Initial submission to the registry
March 21, 2021
CompletedFirst Posted
Study publicly available on registry
April 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedNovember 15, 2022
November 1, 2022
1.8 years
March 21, 2021
November 13, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Early wound healing
Early wound healing is measured via appearance of granulation tissue over the wound.
3 weeks
Secondary Outcomes (1)
Decreased hospital stay
4 weeks
Study Arms (2)
Honey
EXPERIMENTALTopical honey to be used for dressing 4ml per square inch.
EUSOL
ACTIVE COMPARATOREUSOL soaked gauze to be placed over the wound as dressing.
Interventions
Eligibility Criteria
You may qualify if:
- Age \>18 years and \<70 years.
- Necrotizing fasciitis wounds
- Wide span of wound \<20cm
You may not qualify if:
- Diabetic Foot wounds
- Traumatic wounds
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr Ruth K.M Pfau Civil Hospital
Karachi, Sindh, 75000, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 21, 2021
First Posted
April 5, 2021
Study Start
March 1, 2020
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
November 15, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share